(NASDAQ: BGMS) Bio Green Med Solution's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 40.5%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 100.43%.
Bio Green Med Solution's earnings in 2025 is -$6,428,000.On average, 3 Wall Street analysts forecast BGMS's earnings for 2025 to be -$2,694,841, with the lowest BGMS earnings forecast at -$2,589,161, and the highest BGMS earnings forecast at -$2,774,101. On average, 3 Wall Street analysts forecast BGMS's earnings for 2026 to be -$2,557,815, with the lowest BGMS earnings forecast at -$2,457,509, and the highest BGMS earnings forecast at -$2,633,045.
In 2027, BGMS is forecast to generate $8,381,413 in earnings, with the lowest earnings forecast at $8,052,730 and the highest earnings forecast at $8,627,925.